Peter Rieckmann, MD
UNIVERSITY OF BRITISH COLUMBIA
Peter Rieckmann, MD, FRCPC, is the Chair of Multiple Sclerosis Research and Director of the Multiple Sclerosis Program at University of British Columbia, Canada, and holds a position as Professor of Neurology and Research Group Leader for Multiple Sclerosis and Neuroimmunology at University of Wuerzburg, Germany. Dr. Rieckmann has expertise in the pathophysiology and treatment of neuroimmunological disorders, multiple sclerosis, and molecular and functional aspects of blood-brain barrier disturbances. He has published over 152 original articles in peer reviewed journals, 21 book chapters, two textbooks, and has presented over 200 invited lectures. Dr. Rieckmann is a member of the European Committee for Trials and Research in Multiple Sclerosis, on the medical advisory board of the Multiple Sclerosis International Federation, Vice President of the German Multiple Sclerosis Society, the steering committee of various international multiple sclerosis trials, and is Coordinator of the Multiple Sclerosis Therapy Consensus Group. (This is me - Update Profile)
| 2007 - present | Professor of Neurology and MS Research Chair UNIVERSITY OF BRITISH COLUMBIA |
|---|---|
| 2001 - present | Professor of Neurology and Research Group Leader Bayerische Julius-Maximilians-Universitaet Wuerzburg |
GLG Study Groups with Peter Rieckmann, MD(?)
| Study Group Name | Members |
|---|---|
| Neurologists | 1823 |
| Tysabri Prescribers for Multiple Sclerosis: Neurologists | 71 |
| Copaxone Prescribers for Multiple Sclerosis | 87 |
GLG NewsSM Analyses by Peter Rieckmann, MD(?)
View all GLG News in Healthcare
GLG InstituteSM Seminars with Peter Rieckmann, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Peter Rieckmann, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

